• WNT5a/GSK3/β-catenin Axis Controls FAP Adipogenesis in Muscl

  2026-06-12

  This study uncovers the WNT5a/GSK3/β-catenin signaling axis as a critical regulator of adipogenic differentiation in skeletal muscle fibro/adipogenic progenitors (FAPs). The findings provide mechanistic insight into how modulating this pathway can influence muscle regeneration and counteract fatty degeneration, with implications for translational research in myopathies and muscle biology.

• NF 340: A Selective P2Y11 Antagonist Transforming GPCR Resea

  2026-06-12

  NF 340 empowers researchers to precisely interrogate P2Y11-driven GPCR signaling—vital for dissecting immune modulation, inflammation, and cancer cell invasiveness. Its robust selectivity, as highlighted in recent mechanistic studies, streamlines protocol optimization and troubleshooting for reliable experimental outcomes.

• Acacetin–MAPK1/HMOX1 Axis Regulates Pyroptosis in IVDD Thera

  2026-06-11

  This study identifies a novel mechanism by which Duhuo Jisheng decoction (DHJS) and its active component acacetin alleviate intervertebral disc degeneration (IVDD) through the MAPK1/HMOX1 axis, inhibiting nucleus pulposus cell pyroptosis and enhancing mitophagy. These findings provide foundational insight into mitophagy–pyroptosis crosstalk as a therapeutic target for degenerative disc disease.

• Tin Mesoporphyrin IX: Applied Strategies for Heme Oxygenase

  2026-06-11

  Tin Mesoporphyrin IX (chloride) is redefining metabolic and virological research workflows with unparalleled potency and selectivity as a heme oxygenase inhibitor. This article details stepwise protocols, advanced troubleshooting, and the translational impact of leveraging APExBIO’s rigorously benchmarked compound in both metabolic and viral disease models.

• Spiroplasma eriocheiris Entry Mechanisms in Drosophila S2 Ce

  2026-06-10

  Wei et al. (2019) reveal that Spiroplasma eriocheiris invades Drosophila Schneider 2 cells via clathrin-mediated endocytosis and macropinocytosis, with infection critically dependent on intact microtubule and actin cytoskeletons. These findings deepen the understanding of host-pathogen interactions in invertebrate models and open avenues for dissecting cytoskeletal contributions to infection processes.

• DeferoxamineB: Precision Iron Modulation for Regulated Cell

  2026-06-10

  This article explores how Deferoxamine (DeferoxamineB) enables translational researchers to leverage iron chelation for the strategic modulation of ferroptosis and cuproptosis in cancer research. Integrating mechanistic insights, state-of-the-art protocol guidance, and the latest evidence on metabolic interventions, this thought-leadership piece elevates the conversation beyond routine product pages—offering actionable strategies for scientists pursuing next-generation regulated cell death therapies.

• Transcription Termination Limits DNA Damage After WEE1 Inhib

  2026-06-09

  This study demonstrates that efficient transcription termination is critical for preventing DNA damage following WEE1 kinase inhibition, highlighting a new regulatory layer in genome integrity maintenance. The findings have significant implications for designing combinatorial cancer therapies targeting transcription-replication conflicts.

• siRNA Nanoparticles Target TDRD9 to Mitigate P. aeruginosa L

  2026-06-09

  This study introduces a hyaluronic acid sodium salt-coated siRNA nanoparticle platform targeting TDRD9 in neutrophils, uncovering a mechanism of enhanced cuproptosis that reduces Pseudomonas aeruginosa-induced lung injury. The findings provide a new direction for immune modulation therapies in bacterial pneumonia.

• SlSLAH1-Mediated Malate Exudation Pathway in Tomato Aluminum

  2026-06-08

  This study identifies the SlSLAH1 anion channel as a key plasma membrane malate transporter regulated by the transcription factor SlSTOP1, conferring aluminum (Al) tolerance in tomato. By defining a novel regulatory module involving SlSLAH1, SlSLAH2, and SlSTOP1/SlSZP1, the work advances mechanistic understanding of Al detoxification and offers new targets for engineering aluminum-tolerant crops.

• Cy7 NHS Ester: Protocol Guide for Near-Infrared Protein Labe

  2026-06-08

  Cy7 NHS ester is a sulfonated, water-soluble near-infrared dye that enables efficient, low-quenching labeling of proteins and peptides for live cell and tissue imaging applications. It solves common issues with hydrophobic dye aggregation and is ideal for protocols requiring high sensitivity and compatibility with delicate biomolecules. However, its use is not recommended for long-term storage of labeled conjugates or for non-amino group labeling workflows.

• Connexin 43 and EAATs in Breakthrough Cancer Pain: Insights

  2026-06-07

  This study introduces a rigorously validated mouse model of breakthrough cancer pain (BTcP) and delineates a mechanistic link between spinal astrocytic EAAT downregulation, enhanced connexin 43 phosphorylation, and pain hypersensitivity. The findings highlight the therapeutic potential of targeting astrocytic gap junctions and excitatory amino acid transporters for BTcP intervention.

• Dextrose (D-glucose): Optimizing Glucose Metabolism Research

  2026-06-06

  Dextrose (D-glucose) empowers researchers to dissect metabolic reprogramming and immune cell function in hypoxic tumor microenvironments. This guide details actionable workflows, troubleshooting strategies, and protocol enhancements that leverage APExBIO’s high-purity D-glucose for reproducible, high-impact metabolic research.

• URB597 (KDS-4103): Precision FAAH Inhibition in Translationa

  2026-06-05

  Explore how URB597 (KDS-4103) empowers translational researchers to dissect and manipulate endocannabinoid signaling in pain and neuroinflammation. This article bridges mechanistic insight, recent evidence, and strategic guidance for deploying selective FAAH inhibition in rigorous, reproducible workflows—escalating beyond standard product pages to address emerging challenges in multidimensional preclinical models.

• Dextrose (D-glucose) in Glucose Metabolism Research Workflow

  2026-06-05

  Dextrose (D-glucose) stands at the forefront of metabolic research, empowering precise assays in hypoxia-driven immunometabolism and cellular energy production. This guide delivers actionable protocols, advanced applications, and troubleshooting tips for leveraging APExBIO’s high-purity reagent in cutting-edge cancer and diabetes studies.

• Niclosamide: STAT3 Inhibition Workflows for Cancer Research

  2026-06-04

  Niclosamide, a small-molecule STAT3 signaling pathway inhibitor, enables reliable cell cycle arrest and apoptosis assays in translational oncology. This guide bridges recent high-grade glioma findings with practical protocol enhancements, troubleshooting, and comparative insights for advanced cancer research workflows.

15014 records 1/1001 page Next 12345 下5页 Last page